New wound therapy for rare skin disease shows early promise

NCT ID NCT05120726

Terminated Disease control Sponsor: Louisiana State University Health Sciences Center in New Orleans Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a treatment for pyoderma gangrenosum, a rare skin condition that causes painful, hard-to-heal ulcers. Researchers used a special wound covering made from donated placenta tissue (EpiFix) followed by skin grafts. The study was stopped early after only 5 people enrolled, so we don't have strong results yet. The goal was to see if this approach could help wounds heal and reduce pain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PYODERMA GANGRENOSUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pyoderma gangrenosum

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PYODERMA GANGRENOSUM

Contacts and locations

Show contact details

Locations

LSU Healthcare Network Clinic

Metairie, Louisiana, 70006, United States
Ochsner Baptist Medical Center

New Orleans, Louisiana, 70115, United States
University Medical Center

New Orleans, Louisiana, 70112, United States